Efficacy of Novel Third-Generation Tyrosine Kinase Inhibitors for Uncommon <em>EGFR</em> Mutations – an In Vitro StudyHana Oiki(Kindai University), Yasuhiro Tsutani(Hiroshima University)Preprints.orgAugust 4, 202510.20944/preprints202508.0077.v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersPotential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms—An In Vitro Study|Biomedicines|2024|11Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study|Cells|2025|1